BioMall
Brand Store/BDB Bioscience/BD HorizonTM R718 Mouse Anti-Human IL-13 Receptor alpha2 (CD213a2)
BD HorizonTM R718 Mouse Anti-Human IL-13 Receptor alpha2 (CD213a2)
GENERAL CATALOGUE

BD HorizonTM R718 Mouse Anti-Human IL-13 Receptor alpha2 (CD213a2)

570033 · 100 Tests

BDB Bioscience · Cat: 570033

₹370 – ₹550 approx.This price excludes freight and taxes. Please RFQ to get the final price.

Reach 3+ verified distributors

Catalog No: 570033
Category: reagents
Pack Size: 100 Tests
Brand: BDB Bioscience

Description

Flow cytometric analysis of IL-13 Receptor alpha2 CD213a2 expression on A-375 cells. Cells from the Human A-375 Malignant melanoma, ATCC CRL-1619 cell line were stained with either BD Horizon R718 Mouse IgG1, kappa Isotype Control Cat. No. 566928; dashed line histogram or BD Horizon R718 Mouse Anti-Human IL-13 Receptor alpha2 CD213a2 antibody Cat. No. 570033/570114; solid line histogram . DAPI 4,6-Diamidino-2-Phenylindole, Dihydrochloride Solution Cat. No. 564907 was added to cells right before analysis. The fluorescence histogram showing IL-13 Receptor alpha2 CD213a2 expression or Ig Isotype control staining was derived from gated events with the forward and side light-scatter characteristics of viable DAPI-negative A-375 cells. Flow cytometry and data analysis were performed using a BD X-20 LSRFortessa Cell Analyzer System and FlowJo software. Flow cytometric analysis of IL-13 Receptor alpha2 CD213a2 expression on A-375 cells. Cells from the Human A-375 Malignant melanoma, ATCC CRL-1619 cell line were stained with either BD Horizon R718 Mouse IgG1, kappa Isotype Control Cat. No. 566928; dashed line histogram or BD Horizon R718 Mouse Anti-Human IL-13 Receptor alpha2 CD213a2 antibody Cat. No. 570033/570114; solid line histogram . DAPI 4,6-Diamidino-2-Phenylindole, Dihydrochloride Solution Cat. No. 564907 was added to cells right before analysis. The fluorescence histogram showing IL-13 Receptor alpha2 CD213a2 expression or Ig Isotype control staining was derived from gated events with the forward and side light-scatter characteristics of viable DAPI-negative A-375 cells. Flow cytometry and data analysis were performed using a BD X-20 LSRFortessa Cell Analyzer System and FlowJo software. Show More Flow cytometric analysis of IL-13 Receptor alpha2 CD213a2 expression on A-375 cells. Cells from the Human A-375 Malignant melanoma, ATCC CRL-1619 cell line were stained with either BD Horizon R718 Mouse IgG1, kappa Isotype Control Cat. No. 566928; dashed line histogram or BD Horizon R718 Mouse Anti-Human IL-13 Receptor alpha2 CD213a2 antibody Cat. No. 570033/570114; solid line histogram . DAPI 4,6-Diamidino-2-Phenylindole, Dihydrochloride Solution Cat. No. 564907 was added to cells right before analysis. The fluorescence histogram showing IL-13 Receptor alpha2 CD213a2 expression or Ig Isotype control staining was derived from gated events with the forward and side light-scatter characteristics of viable DAPI-negative A-375 cells. Flow cytometry and data analysis were performed using a BD X-20 LSRFortessa Cell Analyzer System and FlowJo software.

More from BDB Bioscience